A face cream based on high-purity Artemisia argyi extract and its preparation method
A liquid crystal structure stabilizer was prepared by esterification reaction. Combined with high-purity Artemisia argyi extract and other lipid components, a stable liquid crystal network was formed, which solved the problems of unstable liquid crystal structure and short-lasting release of functional molecules, thus achieving long-lasting moisturizing and repairing effects of the face cream.
Patent Information
- Application Number
- CN202610555630.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-04-24
- Publication Date
- 2026-07-10
AI Technical Summary
Existing barrier repair face creams have poor liquid crystal structure stability, resulting in poor water-locking effect, and the functional molecules of high-purity Artemisia argyi extract do not release for long enough, resulting in low repair efficiency.
A liquid crystal structure stabilizer was prepared by esterification reaction. A stable liquid crystal network was formed by polyglycerol-10 and octenyl succinic anhydride. Combined with high-purity Artemisia argyi extract, ceramide, cholesterol and fatty acids, a stable micro reservoir was formed, which improved the stability and water-locking ability of the liquid crystal structure.
It achieves long-term stability of the liquid crystal structure and long-term repair ability of high-purity Artemisia argyi extract, with a cumulative release rate of ≤71.8% over 12 hours, significantly improving the moisturizing and repairing effects of the face cream.
Smart Images

Figure CN122351099A_ABST
Abstract
Description
Technical Field
[0001] This application belongs to the technical field of high-purity Artemisia argyi extract face cream, and in particular relates to a face cream based on high-purity Artemisia argyi extract and its preparation method. Background Technology
[0002] As the largest organ in the human body, the skin's stratum corneum serves as its protective barrier, preventing the invasion of harmful external substances and significantly influencing aspects such as skin hydration and elasticity. However, modern lifestyles, environmental pollution, and genetic factors can easily damage this barrier, leading to decreased water retention, dryness, flaking, and inflammatory reactions, and even exacerbating skin conditions like atopic dermatitis. Therefore, developing skincare products that combine barrier repair, soothing and anti-inflammatory properties with long-lasting hydration has become a core challenge in the fields of cosmetic science and dermatology.
[0003] Artemisia argyi, a traditional Chinese medicine, is rich in active ingredients such as flavonoids, volatile oils, triterpenes, and polysaccharides. Among them, flavonoids can significantly inhibit the release of inflammatory factors such as IL-1α and TNF-α, exerting anti-inflammatory, antioxidant, and antibacterial effects, and promoting the healing of damaged skin. Patent CN118648689A discloses a fermentation method for Artemisia argyi leaves and a method for preparing and applying its extract, providing a high-quality raw material basis for the development of related products. The application of high-purity Artemisia argyi extract mixed with liquid crystal emulsifiers in barrier repair face creams has high application value.
[0004] Despite this, current commercially available barrier-repairing face creams have significant technical limitations: while exogenous lipid-supplemented creams mimic the "golden ratio" of ceramides and other ingredients, the lipids are mostly simple mixtures, and even after treatment with liquid crystal emulsifiers, the synergistic sustained-release effect remains insufficient, resulting in low repair efficiency and short-lived efficacy. On the other hand, while commonly used liquid crystal emulsification systems can form sustained-release carriers, they generally suffer from poor liquid crystal structure stability and susceptibility to environmental factors, leading to poor water retention. Therefore, there is a need to find a face cream based on high-purity Artemisia argyi extract that can achieve long-lasting barrier repair and improve the water-locking and repairing capabilities of face creams, as well as its preparation method. Summary of the Invention
[0005] To address the aforementioned issues and further enhance the long-lasting repair effect of face cream while improving its water-locking ability, this application provides a face cream based on a high-purity extract of Artemisia argyi and its preparation method.
[0006] This application first provides a face cream based on a high-purity Artemisia argyi extract, comprising the following components: a high-purity Artemisia argyi extract; a biomimetic lipid mixture comprising ceramides, cholesterol, and fatty acids; a liquid crystal emulsifier comprising sorbitan olive oil ester; a liquid crystal structure stabilizer; and excipients; The liquid crystal structure stabilizer is obtained by esterification of polyglycerol-10 and octenyl succinic anhydride. The preparation method of the liquid crystal structure stabilizer includes the following steps: S01. Take polyglycerol-10, disperse it in water, and then adjust the pH with sodium hydroxide solution to obtain solution A for later use; S02. Take octenyl succinic anhydride, disperse it in ethanol, then slowly add it dropwise to solution A, heat the reaction, then adjust the pH again, and finally purify and dry to obtain the product.
[0007] Furthermore, in step S01, the pH is adjusted to 7.8-8.5.
[0008] Furthermore, in step S02, the dropping rate is 0.1-0.3 mL / min, and the pH is adjusted again to 6.0-7.0; the heating reaction is carried out at 30-40℃ for 0.5-2 hours.
[0009] Furthermore, based on a total weight of 100 parts of face cream, the content of each component includes the following: 2-3 parts by weight of high-purity Artemisia argyi extract; 0.1-1 parts by weight of ceramide; Cholesterol 0.1-1 part by weight; Fatty acids 0.1-0.8 parts by weight; 2-5 parts by weight of sorbitan oleic acid esters; Liquid crystal structure stabilizer 0.5-1.5 parts by weight.
[0010] Furthermore, the fatty acid is selected from one or more of stearic acid, palmitic acid, and myristic acid.
[0011] Furthermore, the excipients include humectants, emollients, preservatives, and pH adjusters; the humectant is selected from one or more of glycerin and 1,3-butanediol; the emollient is selected from one or more of caprylic / capric triglyceride, squalane, and cetearyl alcohol.
[0012] This application also provides a method for preparing a face cream based on a high-purity extract of Artemisia argyi, which is prepared using the above method and includes the following steps: (1). Aqueous phase preparation: Add liquid crystal structure stabilizer and humectant to deionized water, stir to dissolve, heat to 75-85℃, and keep warm for later use; (2). Oil phase preparation: Sorbitan olive oil ester, ceramide, cholesterol, fatty acid and emollient are mixed, heated to 75-85℃, stirred until completely melted, and kept warm for later use; (3). Emulsification and self-assembly: Under homogenization conditions, the oil phase is slowly added to the aqueous phase and homogenized for 3-10 minutes. Then, the system is cooled to 45-60℃, and the high-purity extract of Artemisia argyi is added and stirred evenly. Then, the temperature is further cooled to below 40℃, and the preservative and pH adjuster are added to adjust the pH to 5.5-6.5. The mixture is stirred evenly and then discharged.
[0013] Furthermore, in step (3), the homogenization rotation speed is 8000-12000 rpm; the cooling rate is 0.5-1.5℃ / min.
[0014] Compared with the prior art, this application has the following beneficial effects: 1. This application describes a liquid crystal structure stabilizer obtained by esterifying polyglycerol-10 with octenyl succinic anhydride. The hydrophobic octenyl chain can insert into the hydrophobic region of the liquid crystal bilayer formed by sorbitan olive oil ester, while the unreacted hydroxyl groups at the hydrophilic head of the polyglycerol-10 can form a multi-site hydrogen bond network with the polar heads of adjacent sorbitan olive oil ester molecules. Through synergistic effects, discrete liquid crystal layers are connected into a stable three-dimensional network structure, enhancing the stability of the liquid crystal structure and improving its water-locking ability.
[0015] 2. The liquid crystal structure reinforced by the liquid crystal structure stabilizer in this application can form a stable "micro reservoir" that can efficiently encapsulate functional molecules such as high-purity Artemisia argyi extract, thereby improving the long-term repair of the damaged skin barrier by functional molecules during cream application. When used, the cumulative release rate of total flavonoids in high-purity Artemisia argyi extract is ≤71.8% over 12 hours, demonstrating long-term repair capabilities. Attached Figure Description
[0016] Figure 1 The data represent the changes in the cumulative release rate of total flavonoids over time in Examples 1-3 and Comparative Examples 1-2 of this application. Detailed Implementation
[0017] To make the inventive purpose, technical solution, and beneficial technical effects of this application clearer, the following detailed description of this application is provided in conjunction with embodiments. All other embodiments obtained by those skilled in the art based on the embodiments in this application without inventive effort are within the scope of protection of this application. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those skilled in the art to which this application pertains. The terminology used herein is for the purpose of describing particular embodiments only and is not intended to limit the application. The term "and / or" as used herein includes any and all combinations of one or more of the associated listed items.
[0018] When using “including,” “having,” and “contains” as described herein, the intention is to cover non-exclusive inclusion, unless an explicit qualifying term such as “only,” “consisting of,” etc., is used, in which case another component may be added.
[0019] The terms "preferred," "more preferably," "better," and "even better" used in this application refer to embodiments of this application that provide certain beneficial effects under certain circumstances. However, other embodiments may also be preferred under the same or other circumstances. Furthermore, the description of one or more preferred embodiments does not imply that other embodiments are unavailable, nor is it intended to exclude other embodiments from the scope of this application. That is, in this application, "preferred," "more preferably," "better," and "even better" are merely descriptions of implementations or embodiments with better effects, but do not constitute a limitation on the scope of protection of this application.
[0020] In this application, terms such as "further," "even more," and "particularly" are used for descriptive purposes and to indicate differences in content, but should not be construed as limiting the scope of protection of this application.
[0021] In this application, "at least one" means one or more, such as one, two, or more. "Multiple" or "several" means at least two, such as two, three, etc., and "multi-layered" means at least two layers, such as two layers, three layers, etc., unless otherwise explicitly specified. In the description of this application, "several" means at least one, such as one, two, etc., unless otherwise explicitly specified.
[0022] When a numerical range is disclosed herein, the range is considered continuous and includes the minimum and maximum values of the range, as well as every value between the minimum and maximum values. Furthermore, when the range refers to integers, it includes every integer between the minimum and maximum values of the range. Additionally, when multiple ranges are provided to describe a feature or characteristic, the ranges may be combined. In other words, unless otherwise specified, all ranges disclosed herein should be understood to include any and all subranges to which they are incorporated.
[0023] Unless otherwise specified, all steps in this application may be performed sequentially or randomly. For example, the method comprising steps (a) and (b) indicates that the method may include steps (a) and (b) performed sequentially, or it may include steps (b) and (a) performed sequentially. For example, the mention that the method may also include step (c) indicates that step (c) may be added to the method in any order; for example, the method may include steps (a), (b), and (c), or it may include steps (a), (c), and (b), or it may include steps (c), (a), and (b), etc. Unless otherwise stated, singular terms may include plural forms and should not be construed as having a quantity of one.
[0024] In this application, "above" or "below" includes the number itself. For example, "below 1" includes 1.
[0025] In this application, room temperature refers to 0~40℃, including but not limited to 10~40℃, or further to 20~30℃.
[0026] The present application will be further illustrated by the following examples, but these examples do not limit the scope of the present application.
[0027] When numerical ranges are given in the embodiments, it should be understood that, unless otherwise stated in this application, both endpoints of each numerical range and any value between the two endpoints may be selected. Unless otherwise defined, all technical and scientific terms used in this application have the same meaning as commonly understood by one of ordinary skill in the art. Where specific conditions are not specified in the embodiments, conventional conditions or conditions recommended by the manufacturer shall apply. All reagents or instruments whose manufacturers are not specified are conventional products that can be purchased commercially. In addition to the specific methods, equipment, and materials used in the embodiments, based on the knowledge of the prior art possessed by one of ordinary skill in the art and the description in this application, any prior art methods, equipment, and materials similar to or equivalent to those described, used, or made by the methods, equipment, and materials in the embodiments of this application may be used to implement this application.
[0028] The preparation method of the high-purity Artemisia argyi extract in this application embodiment is based on the application document with publication number CN118648689A.
[0029] Example 1 Disperse 5.0 g of polyglycerol-10 in 30 mL of deionized water and stir at 300 rpm for 20 minutes until the polyglycerol-10 is completely dissolved, forming a homogeneous and transparent solution. Adjust the pH to 7.8 with 3% NaOH solution. Weigh 0.15 g of octenyl succinic anhydride and dilute it three times with 0.45 mL of anhydrous ethanol. Mix well and transfer to a constant pressure dropping funnel. Under continuous stirring (400 rpm), slowly and evenly add the solution dropwise to the polyglycerol-10 solution over 1 hour, controlling the dropping rate at 0.1 mL / min. After the addition is complete, maintain the reaction temperature at 30°C and continue stirring for 0.5 hours. After the reaction is complete, adjust the pH to 6 with 3% HCl solution to terminate the reaction. Transfer the reaction mixture to a dialysis bag (1000 Da) and dialyze against deionized water for 48 hours, changing the deionized water every 8 hours. After dialysis, the solution in the dialysis bag was collected, transferred to a lyophilization bottle, pre-frozen at -80°C for 12 hours, and then dried in a freeze dryer for 48 hours to obtain the liquid crystal structure stabilizer.
[0030] This embodiment specifically provides a face cream based on high-purity Artemisia argyi extract, the formula of which is as follows: Table 1. Cream formulation based on high-purity Artemisia argyi extract, Example 1. The preparation method is as follows: (1) Preparation of phase A: Add liquid crystal structure stabilizer, glycerol and 1,3-butanediol to deionized water, stir to dissolve, heat to 75°C and keep warm for later use.
[0031] (2) Preparation of phase B: Sorbitan olive oil ester, cetearyl alcohol, ceramide NP, cholesterol, stearic acid, caprylic / capric triglyceride and squalane are mixed, heated to 75°C, stirred until completely melted, and kept warm for later use.
[0032] (3) Emulsification and self-assembly: In a homogenizing emulsification tank, phase B was slowly drawn into phase A under high-speed homogenization (3000 rpm). After the drawing was completed, homogenization was continued at a speed of 8000 rpm for 10 minutes to obtain an emulsion.
[0033] (4) Cooling and Addition of Active Ingredients: The emulsion was cooled at a rate of 0.5℃ / min with slow stirring (500 rpm). When the temperature dropped to 45℃, phase C (high-purity Artemisia argyi extract), which had been pre-dispersed evenly with 1,2-hexanediol, was added and stirred evenly. When the temperature dropped to 40℃, phase D (p-hydroxyacetophenone and 1,2-pentanediol) was added and stirred evenly.
[0034] (5) Post-processing: When the temperature drops below 35℃, add phase E (fragrance) and stir evenly. Adjust the pH to 5.5 with 10% citric acid solution, stir evenly, discharge the material, and let it stand for aging for 24 hours.
[0035] Example 2 Disperse 5.0 g of polyglycerol-10 in 30 mL of deionized water and stir at 200 rpm for 20 minutes until the polyglycerol-10 is completely dissolved, forming a homogeneous and transparent solution. Adjust the pH to 8.5 with 3% NaOH solution. Weigh 0.15 g of octenyl succinic anhydride, dilute it three times with 0.5 mL of anhydrous ethanol, mix thoroughly, and transfer to a constant pressure dropping funnel. Under continuous stirring (400 rpm), slowly and evenly add it dropwise to the polyglycerol-10 solution over 1 hour, controlling the dropping rate at 0.3 mL / min. After the addition is complete, maintain the reaction temperature at 40℃ and continue stirring for 2 hours. After the reaction is complete, adjust the pH to 7 with 3% HCl solution to terminate the reaction. Transfer the reaction mixture to a dialysis bag (1000 Da) and dialyze against deionized water for 48 hours, changing the deionized water every 8 hours. After dialysis, the solution in the dialysis bag was collected, transferred to a lyophilization bottle, pre-frozen at -80°C for 12 hours, and then dried in a freeze dryer for 48 hours to obtain the liquid crystal structure stabilizer.
[0036] This embodiment specifically provides a face cream based on high-purity Artemisia argyi extract, the formula of which is as follows: Table 2. Cream formulation based on high-purity Artemisia argyi extract, Example 2. The preparation method is as follows: (1) Preparation of phase A: Add liquid crystal structure stabilizer, glycerol and 1,3-butanediol to deionized water, stir to dissolve, heat to 85°C and keep warm for later use.
[0037] (2) Preparation of phase B: Sorbitan olive oil ester, cetearyl alcohol, ceramide NP, cholesterol, palmitic acid, caprylic / capric triglyceride and squalane are mixed, heated to 85°C, stirred until completely melted, and kept warm for later use.
[0038] (3) Emulsification and self-assembly: In a homogenizing emulsification tank, phase B was slowly drawn into phase A under high-speed homogenization (3000 rpm). After the drawing was completed, homogenization was continued at a speed of 12000 rpm for 3 minutes to obtain an emulsion.
[0039] (4) Cooling and addition of active ingredients: The emulsion was cooled at a rate of 1.5℃ / min with slow stirring (500 rpm). When the temperature dropped to 60℃, phase C (high-purity Artemisia argyi extract), which had been pre-dispersed evenly with 1,2-hexanediol, was added and stirred evenly. When the temperature dropped to 45℃, phase D (p-hydroxyacetophenone, 1,2-pentanediol) was added and stirred evenly.
[0040] (5) Post-processing: When the temperature drops below 40℃, add phase E (fragrance) and stir evenly. Adjust the pH to 6.5 with 10% citric acid solution, stir evenly, discharge the material, and let it stand for aging for 24 hours.
[0041] Example 3 The difference between this embodiment and Embodiment 1 is that the amount of liquid crystal structure stabilizer is 1.5 parts by weight, the amount of ceramide NP is 0.8 parts by weight, the amount of cholesterol is 0.8 parts by weight, the fatty acid used is myristic acid, and the amount is 0.6 parts by weight. The remaining components and preparation methods are the same as in Embodiment 1.
[0042] Comparative Example 1 The difference between this comparative example and Example 1 is that no liquid crystal structure stabilizer is added, and the deionized water in phase A is made up to 100 parts by weight. The other components and preparation methods are the same as in Example 1.
[0043] Comparative Example 2 The difference between this comparative example and Example 1 is that the amount of liquid crystal structure stabilizer was adjusted to 0.3 parts by weight, and the deionized water in phase A was made up to 100 parts by weight. The remaining components and preparation methods are the same as in Example 1.
[0044] Performance testing 1. Water-locking performance test The water-locking performance was tested using a skin moisture loss tester (model: TewameterTM300).
[0045] Test Method: Thirty female volunteers aged 25-55 years were selected. The skin barrier on the inner arm was slightly damaged using an adhesive tape method. Under constant temperature and humidity (22±1℃, 50±5%RH), the subjects sat still for 30 minutes, and the initial TEWL value (T0) of each test area was measured. Four 2cm×2cm areas were marked on the inner arm of each subject: the corresponding samples of creams from Examples 1-3 and Comparative Examples 1-2 were applied at a standard dosage of 2mg / cm². The TEWL value (T1) of each area was measured again at 0.5 hours, 2 hours, 4 hours, 8 hours, and 24 hours after application, according to the formula: The rate of change (W) of TEWL values at different time points was calculated, and the test results are shown in Table 3.
[0046] Table 3. Change rate of TEWL values at different time points in Examples 1-3 and Comparative Examples 1-2. As shown in Table 3, the TEWL reduction rates of Examples 1-3 were significantly better than those of Comparative Examples 1 and 2 at all time points. Among them, Example 2 performed best, achieving a TEWL reduction rate of -52.8% at 8 hours, followed by Example 1. Example 3 was slightly lower than Example 2 but better than Example 3. Comparative Example 1 showed a TEWL reduction rate of only -15.8% at 24 hours, indicating that its barrier repair effect significantly decreased over time. Although the TEWL reduction rate of Comparative Example 2 was better than that of Comparative Example 1, it was still significantly lower than that of Examples 1-3.
[0047] 2. Sustained-release performance test Following the national standard GB / T27818-2011, the in vitro release of total flavonoids from the high-purity extract of Artemisia argyi in Examples 1-3 and Comparative Examples 1-2 was tested. The test skin membrane was prepared from pig ear skin, which has similar barrier properties to human skin. Subcutaneous fat was removed, and the skin was stored at -20℃. Before use, it was thawed and washed with pH 7.4 phosphate buffer. The receiving solution was pH 7.4 phosphate buffer. 1 mL samples were taken from the receiving cell at 0.5, 1, 2, 4, 6, 8, 10, and 12 hours. The concentration of total flavonoids in the samples was determined using UV-Vis spectrophotometry at a wavelength of 510 nm, and the cumulative release rate was calculated. The test results are shown below. Figure 1 As shown.
[0048] Depend on Figure 1 It can be concluded that the cumulative release rates of Examples 1-3 at 12 hours were 71.8%, 64.2%, and 69.8%, respectively, indicating a stable and continuous release of flavonoids from the high-purity Artemisia argyi extract during the 12-hour test period. Among them, Example 2 showed the best sustained-release effect, followed by Example 3, and then Example 1. Comparative Example 1 had the highest cumulative release rate of 93.2% at 12 hours, but the worst sustained-release effect; the sustained-release effect of Comparative Example 2 was between that of Comparative Example 1 and Example 1, but still significantly worse than that of the Examples.
[0049] Although this application has been described in detail with reference to the foregoing embodiments, those skilled in the art can still modify the technical solutions described in the foregoing embodiments or make equivalent substitutions for some of the technical features. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of this application should be included within the protection scope of this application.
Claims
1. A face cream based on a high-purity extract of Artemisia argyi, characterized in that, It contains the following components: high-purity Artemisia argyi extract; biomimetic lipid mixture containing ceramides, cholesterol, and fatty acids; liquid crystal emulsifier containing sorbitan olive oil ester; liquid crystal structure stabilizer; excipients; The liquid crystal structure stabilizer is obtained by esterification of polyglycerol-10 and octenyl succinic anhydride.
2. A face cream based on high-purity Artemisia argyi extract according to claim 1, characterized in that, The preparation method of the liquid crystal structure stabilizer includes the following steps: S01. Take polyglycerol-10, disperse it in water, and then adjust the pH with sodium hydroxide solution to obtain solution A for later use; S02. Take octenyl succinic anhydride, disperse it in ethanol, then slowly add it dropwise to solution A, heat the reaction, then adjust the pH again, and finally purify and dry to obtain the product.
3. A face cream based on a high-purity extract of Artemisia argyi according to claim 2, characterized in that, In step S01, the pH is adjusted to 7.8-8.
5.
4. A face cream based on a high-purity extract of Artemisia argyi according to claim 2, characterized in that, In step S02, the dropping rate is 0.1-0.3 mL / min, and the pH is adjusted again to 6.0-7.0; The heating reaction is carried out at 30-40℃ for 0.5-2 hours.
5. A face cream based on a high-purity extract of Artemisia argyi according to claim 1, characterized in that, Based on a total weight of 100 parts of face cream, the content of each component includes the following: 2-3 parts by weight of high-purity Artemisia argyi extract; 0.1-1 parts by weight of ceramide; Cholesterol 0.1-1 part by weight; Fatty acids 0.1-0.8 parts by weight; 2-5 parts by weight of sorbitan oleic acid esters; Liquid crystal structure stabilizer 0.5-1.5 parts by weight.
6. A face cream based on high-purity Artemisia argyi extract according to claim 1, characterized in that, The fatty acid is selected from one or more of stearic acid, palmitic acid, and myristic acid.
7. A face cream based on a high-purity extract of Artemisia argyi according to claim 1, characterized in that, The excipients include humectants, emollients, preservatives, and pH adjusters; the humectants are selected from one or more of glycerin and 1,3-butanediol; the emollients are selected from one or more of caprylic / capric triglycerides, squalane, and cetearyl alcohol.
8. A method for preparing a face cream based on a high-purity extract of Artemisia argyi as described in any one of claims 1-7, characterized in that, Includes the following steps: (1). Aqueous phase preparation: Add liquid crystal structure stabilizer and humectant to deionized water, stir to dissolve, heat to 75-85℃, and keep warm for later use; (2). Oil phase preparation: Sorbitan olive oil ester, ceramide, cholesterol, fatty acid and emollient are mixed, heated to 75-85℃, stirred until completely melted, and kept warm for later use; (3). Emulsification and self-assembly: Under homogenization conditions, the oil phase is slowly added to the aqueous phase and homogenized for 3-10 minutes. Then, the system is cooled to 45-60℃, and the high-purity extract of Artemisia argyi is added and stirred evenly. Then, the temperature is further cooled to below 40℃, and the preservative and pH adjuster are added to adjust the pH to 5.5-6.
5. The mixture is stirred evenly and then discharged.
9. A method for preparing a face cream based on a high-purity extract of Artemisia argyi according to claim 8, characterized in that, In step (3), the homogenization speed is 8000-12000 rpm.
10. A method for preparing a face cream based on a high-purity extract of Artemisia argyi according to claim 8, characterized in that, In step (3), the cooling rate is 0.5-1.5℃ / min.
Citation Information
Patent Citations
Folium artemisiae argyi fermentation method, folium artemisiae argyi extract preparation method and application
CN118648689A
